Clinical Trials
27 trialsA Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
TVATLC01
Hunan Province Tumor Hospital
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd.
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer
Chongqing Precision Biotech Co., Ltd
Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy
Andarix Pharmaceuticals
A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.
ImmVira Pharma Co. Ltd
AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer
Suzhou Junjing BioSciences Co., Ltd.
Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer
First People's Hospital of Hangzhou
Lorlatinib Combinations in Lung Cancer
Massachusetts General Hospital
Microwave Ablation of Primary and Secondary Lung Malignancies
University of Calgary
A Phase I Study of FCN-411 in Advanced Non-small Cell Lung Cancer Chinese Patients With EGFR Positive Mutation
Ahon Pharmaceutical Co., Ltd.
A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
Petra Pharma
CCA-MPLC
Guangzhou Institute of Respiratory Disease
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Shenzhen BinDeBio Ltd.
Antigen-specific T Cells Against Lung Cancer
Shenzhen Geno-Immune Medical Institute
Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A Study of Anti-PD1 Antibody-activated TILs in Non-small Cell Lung Cancer
Sun Yat-sen University
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells
Xuanwu Hospital, Beijing
Postoperative Pain Control With Lipossomic Extended Release Bupivacaine
University of Tennessee
Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC
The First Affiliated Hospital of Guangdong Pharmaceutical University
Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC
West China Hospital
Study of DC-CTL Combined With CIK for Advanced Solid Tumor
Harbin Medical University
D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC)
Shenzhen Hornetcorn Bio-technology Company, LTD
Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Thoracoscopic Lobectomy Using Nonintubated Anesthesia Versus Intubated General Anesthesia for Lung Cancer Patients
National Taiwan University Hospital
Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)
Instituto de Investigação em Imunologia